Enrolled first patients in first 4D-150 Phase 3 clinical trial (4FRONT-1) in wet AMD, with over 50 clinical trial sites open to date Initiation of second 4D-150 Phase 3 clinical trial (4FRONT-2) ...

Publication of the Nalu Real-World Data (RWD) paper in the Chronic Pain and Management Journal is a significant milestone, establishing Nalu peripheral nerve stimulation (PNS) as ...

AI medical scribes can reduce documentation burdens, improve provider productivity and enhance the overall patient experience ...

New approval provides hospitals and clinics in the Czech Republic with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, May 5, 2025 /PRNewswire/ -- Telix Pharmaceuticals ...

Five presentations highlight TERLIVAZ research in adults with HRS with rapid reduction in kidney function,1 also known as HRS-AKI<sup ...

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced it has signed a binding ...

Part 2a is designed to confirm the primary dose-of-interest with a target enrollment of approximately 30 patients at each of two dose levels: 400mg QD 5:2 and 300mg QD 5:2 (intermittent daily dosing ...

GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...

Cantata Health Solutions, a leading provider of healthcare technology solutions for behavioral health and human services providers, announces Arize MAT, a new Medication-Assisted Treatment (MAT) ...

compared with 45.3% of the 446 patients in the clinical surveillance arm. The data were published last year in The New England Journal of Medicine (NEJM), marking the ninth NEJM publication on ...